Global Cancer Diagnostics Device Market Report Details, 2016-2020

Report : Global Cancer Diagnostics Device Market 2016-2020 is a new market research publication announced by Reportstack.

Report Outline: An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex genetic analysis of samples using next-generation sequencing technologies helps researchers analyze the individual and relevant pattern of genetic changes in tumor tissues, helping in determining the most effective treatment options. 

The development of sophisticated technologies such as microarray, next-generation sequencing, mass spectrometry, automated DNA sequencing, fluorescence in-situ hybridization, and comparative genomic hybridization has opened new avenues for cancer biomarkers. These technologies are capable of detecting abnormalities in the gene expression and the genetic structure of cancer cells. In addition, these technologies can analyze changes in the DNA, RNA, and chromosomes from tissue samples of a tumor.

For detailed report with TOC, please click here ​Global Cancer Diagnostics Device Market 2016-2020.

Market Growth: The global cancer diagnostics devices market is expected to grow at a CAGR of 18.07% during the period 2016-2020.

Key vendors: 
• Abbott Diagnostics
• Agilent Technologies
• BD
• bioMérieux
• Qiagen
• Roche Diagnostics

Other prominent vendors: 
• Affymetrix 
• Ambry Genetics 
• Annoroad 
• Aviva Biosciences
• Biochain 
• Bio-Rad
• Cancer Genetics
• Cepheid
• CompanionDx 
• DiagnoCure 
• Epic Sciences 
• Epigenomics 
• Genomic Health 
• HalioDX 
• Hologic 
• Illumina
• Myriad Genetics
• Thermo Fisher Scientific 
• Ventana Medical Systems 
• Vysis

Regions Covered:

• Americas

Companies Mentioned

Abbott Diagnostics, Agilent Technologies, BD, bioMérieux, Qiagen, Roche Diagnostics, Affymetrix, Ambry Genetics, Annoroad, Aviva Biosciences, Biochain, Bio-Rad, Cancer Genetics, Cepheid, CompanionDx, DiagnoCure, Epic Sciences, Epigenomics, Genomic Health, HalioDX, Hologic, Illumina, Myriad Genetics, Thermo Fisher Scientific, Ventana Medical Systems, Vysis.


Debora White

Manager - Marketing

Ph: +1-888-789-6604

Reportstack Market Research